TGM3
Basic information
Region (hg38): 20:2296001-2341079
Links
Phenotypes
GenCC
Source:
- uncombable hair syndrome (Supportive), mode of inheritance: AR
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Uncombable hair syndrome 2 | AR | General | The clinical relevance of the condition is unclear | Dermatologic | 27866708 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TGM3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 12 | |||||
missense | 39 | 50 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 3 | 4 | |||
non coding | 0 | |||||
Total | 0 | 0 | 39 | 13 | 10 |
Variants in TGM3
This is a list of pathogenic ClinVar variants found in the TGM3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
20-2309687-C-A | TGM3-related disorder | Benign (Apr 16, 2019) | ||
20-2309690-C-G | TGM3-related disorder | Likely benign (Nov 21, 2022) | ||
20-2309727-C-T | TGM3-related disorder | Likely benign (Jun 26, 2020) | ||
20-2309772-A-C | not specified | Uncertain significance (Mar 11, 2024) | ||
20-2310205-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
20-2310232-G-A | not specified | Uncertain significance (Oct 05, 2021) | ||
20-2310319-T-C | not specified | Uncertain significance (Aug 10, 2021) | ||
20-2310324-C-T | not specified | Likely benign (Jun 24, 2022) | ||
20-2310333-A-G | not specified | Uncertain significance (May 03, 2023) | ||
20-2311036-C-T | TGM3-related disorder | Likely benign (Jul 09, 2024) | ||
20-2311037-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
20-2311059-A-G | not specified | Uncertain significance (Oct 28, 2023) | ||
20-2311070-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
20-2311076-A-C | TGM3-related disorder | Benign (Nov 25, 2019) | ||
20-2311089-G-A | not specified | Uncertain significance (May 04, 2023) | ||
20-2312908-A-G | not specified | Likely benign (Mar 13, 2023) | ||
20-2312979-G-A | not specified | Uncertain significance (Feb 10, 2022) | ||
20-2317065-C-T | TGM3-related disorder | Likely benign (Dec 09, 2019) | ||
20-2317113-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
20-2317144-G-A | TGM3-related disorder | Benign (Nov 12, 2019) | ||
20-2317249-C-T | TGM3-related disorder | Likely benign (Aug 15, 2024) | ||
20-2317376-C-T | not specified | Uncertain significance (Aug 03, 2021) | ||
20-2317379-G-T | TGM3-related disorder | Uncertain significance (Sep 14, 2024) | ||
20-2317415-C-A | Benign (Jun 22, 2018) | |||
20-2317416-G-A | not specified | Uncertain significance (Jul 20, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TGM3 | protein_coding | protein_coding | ENST00000381458 | 13 | 45078 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000297 | 0.999 | 125695 | 0 | 52 | 125747 | 0.000207 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.411 | 447 | 423 | 1.06 | 0.0000267 | 4568 |
Missense in Polyphen | 159 | 163.06 | 0.97512 | 1815 | ||
Synonymous | -1.18 | 198 | 178 | 1.11 | 0.0000127 | 1363 |
Loss of Function | 2.98 | 15 | 33.7 | 0.446 | 0.00000178 | 342 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000297 | 0.000297 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000163 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000293 | 0.000290 |
Middle Eastern | 0.000163 | 0.000163 |
South Asian | 0.000229 | 0.000229 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the calcium-dependent formation of isopeptide cross-links between glutamine and lysine residues in various proteins, as well as the conjugation of polyamines to proteins. Involved in the formation of the cornified envelope (CE), a specialized component consisting of covalent cross-links of proteins beneath the plasma membrane of terminally differentiated keratinocytes. Catalyzes small proline-rich proteins (SPRR1 and SPRR2) and LOR cross-linking to form small interchain oligomers, which are further cross-linked by TGM1 onto the growing CE scaffold (By similarity). In hair follicles, involved in cross- linking structural proteins to hardening the inner root sheath. {ECO:0000250}.;
- Disease
- DISEASE: Uncombable hair syndrome 2 (UHS2) [MIM:617251]: A form of uncombable hair syndrome, a condition characterized by scalp hair that is impossible to comb due to the haphazard arrangement of the hair bundles. A characteristic morphologic feature is a triangular to reniform to heart shape on cross-sections, and a groove, canal or flattening along the entire length of the hair. Most individuals are affected early in childhood and the hair takes on a spun-glass appearance with the hair becoming dry, curly, glossy, lighter in color, and progressively uncombable. The hair growth rate can range from slow to normal, and the condition improves with age. {ECO:0000269|PubMed:27866708}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.219
Intolerance Scores
- loftool
- 0.320
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 37.76
Haploinsufficiency Scores
- pHI
- 0.360
- hipred
- N
- hipred_score
- 0.380
- ghis
- 0.408
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.538
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Tgm3
- Phenotype
- homeostasis/metabolism phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); limbs/digits/tail phenotype; skeleton phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- cellular protein modification process;peptide cross-linking;keratinocyte differentiation;hair follicle morphogenesis;keratinization;cell envelope organization;protein tetramerization
- Cellular component
- cytoplasm;extrinsic component of cytoplasmic side of plasma membrane;extracellular exosome
- Molecular function
- protein-glutamine gamma-glutamyltransferase activity;catalytic activity;calcium ion binding;transferase activity, transferring acyl groups